APA ציטוט

Bafadhel, M., Sing, D., Jenkins, C., Peterson, S., Bengtsson, T., & Fageras, M. (2018). Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS). European Respiratory Society.

Chicago Style (17th ed.) Citation

Bafadhel, M., D. Sing, C. Jenkins, S. Peterson, T. Bengtsson, and M. Fageras. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.

ציטוט MLA

Bafadhel, M., et al. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.